Shamburg News · 8-K filed Nov 13, 2026, 4:30 PM EST
Indaptus Therapeutics Reports Third Quarter 2026 Financial Results and Corporate Update
INDP · Indaptus Therapeutics, Inc.
- Earnings
- Financing
- Other event
- Materiality: high
Indaptus Therapeutics reported financial results for the third quarter and nine months ended September 30, 2026, and provided a corporate update in a press release dated November 13, 2026. Net loss was approximately $1.0 million for the third quarter of 2026, compared with approximately $3.0 million a year earlier, and basic and diluted net loss per share was approximately $0.01. The company reported approximately $30.6 million in cash, cash equivalents and short-term investments as of September 30, 2026, and referenced a private placement of approximately $24.0 million that closed on October 16, 2026.
Source: SEC EDGAR, Form 8-K, Items 2.02, 9.01, accession 0001493152-26-051749.
Written from the filing by Shamburg Markets. Figures are as reported by the company.